Studies have showed that TIMP2 was highly expressed in the myocardium and had the double effects of activating pro-MMP2 and preventing matrix metalloproteinases (MMP2) activation, thus inhibiting the development of the angiogenesis in the heart failure. This evidence concerns the gene MMP2 and heart failure.